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Cell migration and invasion are highly regulated processes involved in both physiological
and pathological conditions. Here we show that autophagy modulation regulates the
migration and invasion capabilities of glioblastoma (GBM) cells. We observed that during
autophagy occurrence, obtained by nutrient deprivation or by pharmacological inhibition
of the mTOR complexes, GBM migration and chemokine-mediated invasion were both
impaired. We also observed that SNAIL and SLUG, two master regulators of the epithe-
lialemesenchymal transition (EMT process), were down-regulated upon autophagy stimu-
lation and, as a consequence, we found a transcriptional and translational up-regulation of
N- and R-cadherins. Conversely, in BECLIN 1-silenced GBM cells, an increased migration
capability and an up-regulation of SNAIL and SLUG was observed, with a resulting decrease
in N- and R-cadherin mRNAs. ATG5 and ATG7 down-regulation also resulted in an
increased migration and invasion of GBM cells combined to an up-regulation of the two
EMT regulators. Finally, experiments performed in primary GBM cells from patients largely
confirmed the results obtained in established cell cultures.
Overall, our results indicate that autophagy modulation triggers a molecular switch from a
mesenchymal phenotype to an epithelial-like one in GBM cellular models. Since the
aggressiveness and lethality of GBM is defined by local invasion and resistance to chemo-
therapy, we believe that our evidence provides a further rationale for including autophagy/
mTOR-based targets in the current therapeutical regimen of GBM patients.
ª 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights
reserved.gy, University of Rome T
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M O L E C U L A R O N C O L O G Y 9 ( 2 0 1 5 ) 1 6 1 2e1 6 2 5 16131. Introduction To date, only a few studies exist correlating autophagy toCellmigration isa crucial process involved inphysiological con-
ditions during embryogenesis and post-natal development,
and inpathological contexts suchaswoundhealing, inflamma-
tion and tumor metastatization. In order for cells to migrate, a
highly regulated series of events occur within them. It has
emerged that the epithelial-to-mesenchymal transition (EMT)
and its reverse process (MET) are both essential for migration
and invasion (De Craene and Berx, 2013; Nakaya and Sheng,
2013; Thompson and Williams, 2008; Acloque et al., 2009). In
particular, EMT plays a critical role in tumor spreading and
dissemination; once they activate EMT program, tumoral cells
acquire an invasive phenotype that allows them to detach
fromtheprimarysite and invadesurrounding tissuesandblood
vessels. The reverse MET process is believed to be responsible
for establishment and stabilization of metastases, following
re-acquisition by tumoral cells of epithelial-like properties
(Thompson and Williams, 2008). Differently from EMT, that
has been widely investigated in recent years, only few studies
exist onMET and its regulation duringmetastatization. A num-
ber of factors regulate the EMT/MET processes, among which
are the SNAI family members SNAIL and SLUG that encode
zinc finger-containing transcriptional factors (Hemavathy
et al., 2000; Peinado et al., 2007). SNAIL and SLUG are known
to repress E-cadherin expression in epithelial cells undergoing
EMT, but no information exist on their role on other members
of the cadherin family, neither additional roles on target genes.
TheWnt/b-catenin pathway has also been involved in EMT, by
promoting transcription and stabilization of SNAIL (Zhou and
Hung, 2005; Yook et al., 2005; Stemmer et al., 2008). Moreover,
it has been demonstrated that SNAIL can interact with b-cate-
nin, thereby promoting Wnt-dependent gene expression
(Stemmer et al., 2008).
Autophagy is an evolutionary conserved processmediating
degradation of cytoplasmic material, such as long-lived pro-
teins and old or damaged organelles (Mizushima and
Komatsu, 2011; Di Bartolomeo et al., 2010a). During auto-
phagy, double-membrane vesicles form (the autophago-
somes), surrounding and carrying the cytoplasmic material
to lysosomes for degradation (Choi et al., 2013; Boya et al.,
2013). In physiological conditions, autophagy contributes to
themantainance of a proper cellular homeostasis and is regu-
lated by a signal transduction pathway involving the mTOR
protein kinase. In the presence of nutrients,mTOR is activated
and the autophagy initiation impaired, by inhibition of the
Ulk1 complex (Nazio et al., 2013). In shortage of nutrients
(mainly aminoacids) mTOR is inhibited and Ulk1 complexes
can drive autophagosome formation (Boya et al., 2013; Di
Bartolomeo et al., 2010b). The role of autophagy in tumor
onset and progression is still a matter of debate; in fact, this
process has been proposed to have a protective role for tumor
initiation, by limiting genome instability and preventing accu-
mulation of damaged organelles and proteins (Choi, 2012).
Otherwise, established cancer cells probably use autophagy
to promote their survival in a hypoxic and stressful microen-
vironment so as to escape both the physiological response to
cancer and therapy (Kimmelman, 2011; Guo et al., 2013;
White, 2012).cell migration and invasion. Autophagy activation has been
associated to the degradation of the EMT regulators SNAIL
and TWIST in breast cancer models (Lv et al., 2012). Moreover,
it has been demonstrated that there is high activity of mTOR
protein kinase and low levels of autophagy during migration,
and that pharmacological or genetic inhibition of mTOR
signaling attenuated the migration of colon and hepatocellu-
lar cancer cells and that mTORC1/2 down-regulation induced
MET (Gulhati et al., 2011; Liao et al., 2015). mTOR inhibition
induced cytoskeleton rearrangements, increased cellecell
contacts and decreased the activity of the small GTPases
RhoA and Rac1 (Gulhati et al., 2011). By contrast, the knock-
down of the autophagy regulators ATG7, or Atg5 or Atg3 stim-
ulated cell migration of HeLa cells and MEFs respectively
(Tuloup-Minguez et al., 2013).
Autophagy impact on glioblastoma multiforme (GBM) re-
mains poorly investigated, although it has been demonstrated
that a number of autophagy regulators are highly expressed in
GBM belonging to the mesenchymal subtype, and that the
knockdown of some of these genes modifies the migration
and invasion properties of GBM cells (Galavotti et al., 2013;
Macintosh et al., 2012). Autophagy induction has been
observed in GBM in response to radio- and temozolomide-
based therapy; even though a number of clinical trials aimed
at inhibiting autophagy have been launched, others directed
to inhibiting the mTOR pathway are ongoing (Amaravadi
et al., 2011; Galanis et al., 2005; Nghiemphu et al., 2012;
Dufour et al., 2011). Furthermore, recently, it has been shown
that the combination of epidermal growth factor (EGFR) down-
regulation and autophagy stimulation impairs clonogenic and
migration capability of T98G and U373MG glioma cells
exposed to irradiation (Palumbo et al., 2014).
Here we show that autophagy modulation regulates the
migration and the invasion capabilities of GBM cells by
down-regulating EMTmaster factors. GBM, themost common
and lethal adult brain tumor, is characterized by an highly
invasive behavior. Overall, our data suggest that therapeutical
strategies targeting autophagy should take into account any
possible effects on GBM invasiveness.2. Results
2.1. Autophagy is induced in glioma cell lines upon
aminoacid deprivation and mTOR inhibitors treatment
To determine the response of GBM cell lines to autophagic
stimuli, the human GL15 and U87MG cells were incubated in
an aminoacid-free and serum-free medium Earle’s Balanced
Salt Solution (EBSS), and then analyzed, at different time
points, for autophagy occurrence by means of LC3I to LC3II
conversion and by checking p62 down-regulation. As shown
in Figure 1a, both markers indicate a time-dependent induc-
tion of autophagy. Upon 18 h of EBSS incubation, a further
degradation and disappearance of LC3II can be observed in
the absence of Chloroquine (CQ), a drug known to inhibit auto-
phagosome to lysosome fusion and widely used to monitor
the autophagic flux.
Figure 1 e Induction of autophagy in glioma cells lines. (a) Human GL15 and U87MG cells were incubated in aminoacid- and serum-free medium
(EBSS) for the indicated time points in presence or absence of 20 mM Chloroquine (CQ) that impairs autophagosome-to-lysosome fusion and
autophagy completion. After cell lysis, protein extracts were subjected to western blotting analysis by using specific antibodies for the autophagy
markers LC3I/II and p62. Actin was used as loading control. The blots are representative of three independent experiments. (b) Human GL15 and
U87MG and murine GL261 cell lines were incubated for 18 h in aminoacid- and serum-free medium (EBSS) or in a rich medium containing
250 nM Torin 1 or 100 nM Rapamycin. After cell lysis, protein extracts were subjected to western blotting analysis by using specific antibodies for
the mTOR substrates S6Kinase (S6K) and 4EBP1. Specific antibodies were used for the phosphorylated forms of both (phospho-S6KThr389 and
phospho-4EBP1Thr37/46). The same protein extracts were subjected to western blotting analysis for the autophagy markers LC3I/II and p62. Actin
was used as loading control. This blot is representative of three independent experiments.
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autophagic drugs, the mTOR inhibitors Rapamycin and Torin
1 (Torin), were used and their capability to impair the mTOR
pathway and to induce autophagy were tested. As shown inFigure 1b, in human GL15 and U87MG and in the mouse
GL261 cell lines autophagy was fully activated following star-
vation and, at a lesser extent, uponmTOR inhibition at 18 h, as
demonstrated by autophagy markers LC3 and p62.
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demonstrated the effective mTOR signaling inhibition in the
GBM cell lines treated with EBSS, Torin or Rapamycin
(Figure 1b). None of the treatments affected cell viability for
up to 48 h, as demonstrated by citofluorimetric analysis of
propidium iodide-stained cells and by morphological analysis
(not shown).
2.2. Starvation and pharmacological mTOR inhibition
negatively regulate cell migration and invasion in glioma cell
lines
Next, we analyzed themigration capability of GBM cell lines in
autophagy-stimulating conditions (starvation andmTOR inhi-
bition) by means of a wound healing assay. We observed a
strong inhibition of chemokinesis in EBSS grown-cells and,
at a lesser extent, in Torin and Rapamycin-treated cells in
comparison with control cells (Figure 2a, Suppl. Figure S1
and Suppl. Video 1). The wound healing assay was performed
in presence of 5 mM hydroxyurea to exclude the contribution
of cell proliferation to the observed phenomena. Prompted by
these results, we decided to test the effect, if any, of auto-
phagy modulation on CXCL12-induced invasion. GBM cells
are known to express high levels of CXCR4 receptor that allow
them tomigrate both in vitro and in vivomodels in response to
the chemokine CXCL12 (Rubin et al., 2003). By means of a
transwell-based assay, in the presence of matrigel, we
observed an evident reduction of spontaneous cell invasion
in all the three cell lines analyzed when incubated in EBSS
and in Torin-containing medium (Figure 2b and Suppl.
Figure S1, clear columns); moreover, an almost complete
impairment of the capability to respond to CXCL12 was
observed in these conditions (Figure 2b and Suppl. Figure S1,
dark columns). We also analyzed the cellular invasion in
Rapamycin-containing medium and we found a slight but sig-
nificant reduction of both spontaneous and CXCL12-mediated
invasion of GL15 and GL261, but not of U87MG cells (Figure 2b
and Suppl. Figure S1). This result is in line with the evidence of
a lesser capability of Rapamycin to induce autophagy in our
model systems. To rule out the possibility that the invasion
impairment observed in autophagic conditions was due to
an autophagy-mediated degradation of the CXCL12 receptor
CXCR4, a western blotting analysis was performed with a spe-
cific antibody. In GL15 and U87MG cells grown for 24 h in EBSS
or in the presence of Torin or Rapamycin, no differences were
observed in CXCR4 expression levels (Suppl. Figure S2a), even
if in the presence of the protein synthesis inhibitor cycloexi-
mide (CHX) (Suppl. Figure S2b).
Supplementary videos related to this article can be found
online at http://dx.doi.org/10.1016/j.molonc.2015.04.016.
2.3. Autophagy inhibition stimulates cell migration and
invasion in GL15 glioma cells
To confirm the inhibitory role of autophagy on cell chemoki-
nesis, we decided to analyze the migration capability
of BECLIN 1-depleted GBM cells. BECLIN 1, in fact, is one of
the main autophagy regulators driving the autophagosome
formation in basal conditions and upon canonical autophagystimulation. GL15 cells were infected with a lentivirus
carrying a BECLIN 1-specific short hairpin RNA (shRNA) or an
unrelated shRNA, and the effect on autophagy was evaluated
by western blotting for p62 and LC3I/II. BECLIN 1 down-
regulation resulted in p62 accumulation and LC3I/II increase
in GL15 cells, showing an impairment of basal autophagy
(Figure 3a, left panel). When subjected to wound healing assay
in complete medium (DMEM), BECLIN 1-depleted GL15 cells
were able to repair the wound much faster than control cells
(Figure 3a, right panel and Suppl. Video 2), thus confirming
that autophagy is inversely correlated to chemokinesis in
this GBM cell line. A significant reduction of cell migration
was also obtained upon ATG5 and ATG7 down-regulation in
GL15 cells (Figure 3b and Suppl. Figure S3).
Supplementary videos related to this article can be found
online at http://dx.doi.org/10.1016/j.molonc.2015.04.016.
We also analyzed the chemotactic ability of BECLIN 1-
depleted GL15 cells and we found an increase of basal cell in-
vasion, although we did not observe an increased response to
CXCL12 in the absence of BECLIN 1 in comparison to control
cells (Figure 3c, left panel). In order to corroborate the results
obtained, we also analyze the invasion capability of ATG5-
and ATG7-silenced cells that indeed resulted increased
(Figure 3c, right panel and Suppl. Figure S3).
Taken together, these data demonstrate that autophagy in-
duction negatively correlates not only with chemokinesis, but
also with cell invasion. Conversely, turning off autophagy re-
sults in a greater capability of GL15 cells to move across an
extracellular-like matrix.
2.4. The EMT regulators SNAI are down-regulated
during autophagy induction
In order to gain an insight into the molecular mechanisms
involved in the autophagy-mediatedmodulation of cellmigra-
tion and invasion, an analysis of the main EMT/MET players
was performed in the human GBM cell lines. As shown in
Figure 4, both GL15 and U87MG express high levels of SNAI
family members SNAIL and SLUG in control conditions, as ex-
pected for GBM and other highly invasive cancer cells (Jin-Ku
et al., 2014). Upon autophagy induction, obtained by culturing
cells in EBSS for 24 h, a meaningful decrease in SNAIL and
SLUG proteins was observed (Figure 4a). A significant reduc-
tion of SNAIL was also evident after incubation of the cells
with mTOR inhibitors even though to lesser extent; notably,
SLUG levels did not decrease in U87MG cells (Figure 4a). It
was recently shown that SNAIL and TWIST are degraded by
the autophagy-lysosome degradation system in metastatic
breast cancer cells upon PI3K or Beclin 1 overexpression and
viceversa (Lv et al., 2012). To test whether the SNAIL decrease
observed upon autophagy induction in GBM model systems
was due to an autophagy-mediated protein degradation, we
induced autophagy in GL15, by EBSS or Torin administration,
in the presence of MG132 or Chloroquine (CQ), which inhibit
the ubiquitineproteasome and the autophagyelysosome
degradation systems, respectively. The strong increase
observed in control cells in the presence of MG132
(Figure 4b) confirms that SNAIL is mainly a physiological sub-
strate of the proteasome machinery, as described in the
Figure 2 e Impact of starvation and mTOR inhibition on glioma cell migration and invasion. (a) Wound healing assays were performed on GL15
cells in control rich medium (CTR) or in aminoacid- and serum-free medium (EBSS) or in a rich medium containing 250 nM Torin 1 or 100 nM
Rapamycin. 5 mM hydroxyurea was added to the culture media to impair cell proliferation. Phase-contrast images (103 objective) were acquired at
0, 24 and 48 h after scratching and representative images of four independent experiments are shown. The wound healing area was analyzed by
using ImageJ software (NIH) and the corresponding data, relative to 0 h, expressed in the graph. Statistical significance: P< 0.001, one-way
ANOVA. (b) Invasion assays were performed on GL15, in presence of vehicle (DMSO, light gray columns) or 100 nM CXCL12 (dark gray
columns) in DMEM (CTR) or in EBSS or in DMEM containing 250 nM Torin 1 (Torin) or in DMEM containing 1 mMRapamycin. The graphs
shown represent the mean ± SE of at least three different experiments. Statistical significance of CXCL12 versus vehicle in control condition and in
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Figure 3 e Impact of autophagy inhibition on glioma cell migration and invasion. (aeb) GL15 were transduced with a scramble RNA (shCtr) or
with a BECN 1-directed shRNA (shBECLIN) (a) or with an ATG5-directed shRNA (b). Protein extracts were analyzed by western blotting in order
to check the infection efficiency by using antibodies specific for BECLIN 1 and for ATG5 (a and b, respectively, left panels) and the effects of the
interference on autophagy impairment by means of p62 and LC3I/II modulation. b-tubulin and HSP-90 were used as loading controls. Wound
healing assays were performed on BECLIN 1- and ATG5-depleted GL15 cells (shBECLIN and shATG5, respectively) and on control cells
(shCtr) (a and b, right panels). Phase-contrast images were acquired at the indicated time points following scratching. The images are
representative of four independent experiments. The wound healing areas were analyzed by using ImageJ software (NIH) and the corresponding
data, relative to 0 h, expressed in the graph. Statistical significance: P< 0.001, one-way ANOVA. (c) Invasion assay on shCtr and shBECLIN 1-
silenced GL15 cells (left graph) and on shCtr and shATG5 (right graph) in presence of vehicle (DMSO, light gray columns) or 100 nM CXCL12
(dark gray columns). The graphs represent the mean ± SE of four different experiments. **P< 0.001, one-way ANOVA. Statistical significance of
shBeclin or shATG5 vs shCtr is indicated in the absence (##) and presence (xx) of CXCL12. ##P< 0.001; xxP< 0.001; one-way ANOVA.
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ever, when autophagy is induced, an evident reduction of
SNAIL expression was still observed, similar to that observed
in the absence of inhibitors (Figure 4b). Moreover, in the pres-
ence of CQ, which inhibits the autophagosome fusion to lyso-
somes with a concomitant accumulation of LC3II protein, a
slight accumulation of SNAIL was observed in control cells,
this suggesting that autophagy contributes to SNAIL recycling
in basal conditions (Figure 4bec); in the presence of CQ, any-
way, autophagy stimulation still leads to SNAIL down-
regulation in the long time range. Prompted by these results,Rapamycin-treated cells is indicated (**). Statistical significance of EBSS o
presence (xx) of CXCL12. Statistical significance: **P< 0.001, ##P< 0.00we decided to better analyze the kinetics of SNAIL degradation
and found that, 3 h exposure to EBSS or six hours of Torin
treatment are sufficient to trigger an evident reduction of
the protein (Figure 4d). In order to evaluate SNAIL half-life in
our model systems, we treated GL15 and U87MG cells with
the protein synthesis inhibitor cycloeximide (CHX) and
observed that the protein is completely depleted in U87MG
and strongly down-regulated in GL15 cells in a few hours in
normal conditions (Figure 4e). These findings suggest that
the SNAI decrease observed upon sustained autophagy induc-
tion, could be mainly due to a general impairment of ther Torin or Rapamycin vs CTR is indicated in the absence (##) and
1; xxP< 0.001, one-way ANOVA.
Figure 4 e Effect of autophagy induction on EMT regulators. (a) Western blotting of protein extract from U87MG and GL15 cells cultured in
DMEM (Ctr) or EBSS or DMEM containing 250 nM Torin 1 or 100 nM Rapamycin for 18 h was performed by using specific antibodies for
SNAIL and SLUG. ACTIN was used as loading control. (b) GL15 were grown in DMEM (Ctr) or EBSS or incubated, for 18 h, with Torin 1, in
presence of 3 mM MG132 (MG) or 20 mM Chloroquine (CQ). Western blotting analysis of SNAIL was then performed. ACTIN was used as
loading control. Accumulation of LC3II band was used to check CQ efficiency. (c) GL15 were grown in EBSS or in Torin 1 (Torin) for the
indicated time points and the corresponding protein extracts analyzed by Western blotting for SNAIL. TUBULIN was used as loading control. (d)
GL15 and U87MG cells were incubated with 50 mg/ml cycloheximide (CHX) for the indicated times and Western blotting of SNAIL performed.
TUBULIN was used as loading control. (e) GL15 were grown in EBSS for the indicated time points, in the presence or absence of 20 mM
Chloroquine (CQ) and the corresponding protein extracts subjected to western blotting analysis by means of a specific antibody for SNAIL.
ACTIN was used as loading control. (f) Western blotting analysis of SNAIL and SLUG proteins in shCtr, shBECLIN 1- and shATG5-GL15 cells
is shown. All the blot shown are representative of at least three different experiments.
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We also decided to analyze SNAI expression levels in GL15
cells devoid of BECLIN 1 and ATG5; we found an increase of
both SNAIL and SLUG proteins (Figure 4f) thus confirming
our hypothesis about an involvement of the autophagic ma-
chinery in SNAI turnover in basal conditions.
2.5. N- and R-Cadherin expression is affected by
autophagy
SNAI factors are known to negatively regulate cadherin gene
(CDH ) transcription. The CDH superfamily encodes several
types of cadherin differently expressed in tissues. The inhibi-
tory role of SNAIL on E-cadherin expression via repression of
CDH1 promoter is well established. In order to investigate
the effect of SNAI down-regulation on cadherin expressionin GBM cell lines undergoing autophagy, we performed a
Real Time PCR analysis of selected cadherinmRNAs. In partic-
ular, we decided to analyze N- and R-cadherin that are known
to be expressed in the neural tissue. As shown in Figure 5a, we
observed a remarkable increase in N-CAD and R-CAD mRNAs
in both GL15 and U87MG cells grown in EBSS medium or in a
nutrient-rich medium containing Torin. We also analyzed E-
CAD and P-CAD mRNAs that are not expressed in neural tis-
sues in normal conditions; indeed, we found a very low
expression level that did not further increase in autophagic
conditions (data not shown). On the contrary, R-CAD and N-
CAD mRNAs were significantly down-regulated in BECLIN 1-
depleted GL15 cells, in which we know that SNAI proteins
are up-regulated (Figure 5b). Then we decided to analyze the
effect of autophagy on cadherin protein levels by using an
antibody against several members of cadherin superfamily
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Torin 1-treated cells (Figure 5c). As expected, the specific anal-
ysis of E-cadherin protein did not result in any signals bywest-
ern blotting analysis (not shown).
Overall, the results obtained on cadherin mRNAs and pro-
teins demonstrate that the SNAI down-regulation results in
cadherin up-regulation during autophagy induction and vice-
versa in GBM cell lines.
2.6. Autophagy induction regulates migration and
invasion in GBM primary cells
To confirm the results obtained in established cell lines, we
decided to extend our analysis to GBM primary cells obtained
from patients after surgical resection (Sciaccaluga et al., 2013).
Similarly to what we observed in cell lines, both primary cul-
tures almost completely lost their migration capability whenFigure 5 e Cadherin expression upon autophagy modulation. (a) mRNA exp
CAD) obtained by real-time PCR on GL15 (left graph) and U87MG (righ
medium, as indicated in the graph legend. The graphs represent the mean ±
one-way ANOVA. (b) mRNA expression levels of N-CAD and R-CAD ob
scramble RNA (shCtr) or BECN-1-directed RNA (shBECLIN) grown in
ANOVA. (c) Protein extracts from GL15 and U87MG cells grown in DME
blotting analysis of cadherins by using anti-Pan-Cadherin antibody. TUBUgrown inEBSSmedium(Figure6aandSuppl. FigureS4a).Migra-
tion capability was also strongly reduced in cells grown in
Torin-containing medium (Figure 6a and Suppl. Figure S4a).
Cellular invasion following CXCL12 exposure was also evalu-
ated, demonstrating that autophagy induction drastically af-
fects the invasion capability of primary GBM cells (Figure 6b
and Suppl. Figure S4b). Accordingly, SNAIL expression strongly
decreases inEBSSand inpresenceofTorin (Figure6candSuppl.
Figure S4c). Overall, wewere able to reproduce in primary cells
the main results obtained in cell lines, thus confirming the
physio-pathological relevance of our study.3. Discussion
Here we demonstrate the existence of a direct effect of
nutrient starvation and mTOR inhibition on the capability ofression levels of N-CADHERIN (N-CAD) and R-CADHERIN (R-
t panel) cultured in DMEM, EBSS and 250 nM Torin 1-containing
SE of three different experiments. Statistical significance: *P< 0.05;
tained by real-time PCR on GL15 cells after retroviral infection with
control conditions. Statistical significance: *P< 0.05; one-way
M (Ctr), in EBSS and in Torin 1 (Torin) were subjected to Western
LIN was used as loading control.
Figure 6 e Analysis of migration and invasion in primary glioblastoma cells upon autophagy induction. (a) Wound healing assay of a human
primary glioblastoma culture, named GBM47, grown in DMEM (CTR), in EBSS or in Torin-containing DMEM. Phase-contrast
microphotographs (103 objective) were acquired at 0, 24 and 48 h after scratching and representative images of three independent experiments are
shown. The wound healing area was analyzed by using ImageJ software (NIH) and the corresponding data, relative to 0 h, expressed in the graph.
Statistical significance: P< 0.001, one-way ANOVA. (b) Graph showing the results of invasion assays performed on GBM47 grown in DMEM
(CTR), in EBSS or in Torin-containing DMEM, in presence of CXCL12 (dark gray columns) or vehicle (light gray columns). The graph
represents the mean ± SE of three different experiments. Statistical significance of CXCL12 versus vehicle in control condition cells is indicated
(**). Statistical significance of EBSS or Torin vs CTR is indicated in the absence (##) and presence (xx) of CXCL12. Statistical significance:
**P< 0.001, ##P< 0.001; xxP< 0.001, one-way ANOVA. (c) Western blotting analysis of the indicated proteins in cellular extracts from
GBM47 grown in DMEM (CTR), in EBSS or in Torin-containing DMEM for 18 h. ACTIN was used as loading control. This blot is
representative of two different experiments.
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moattractant agent. We clearly observed that autophagy acti-
vation impairs cell migration and invasion and that,
conversely, autophagy inhibition stimulates the same pro-
cess, similarly to what has been observed in highly metastatic
breast, colon and hepatocellular cancer cells (Lv et al., 2012;
Gulhati et al., 2011; Liao et al., 2015). Of note, other literature
data show that the autophagic process is requested by glioma
cells to migrate and that the down-regulation of some auto-
phagy genes limits the cell capability to migrate and invade
(Galavotti et al., 2013; Macintosh et al., 2012). However, the
different model systems (mouse or different human cell lines)
used there as well as completely different time-courses or
most proteins analyzed could explain the apparent variation
with our results. Moreover, we correlate the migration capa-
bilities with amolecular shift from amesenchymal phenotype
to an “epithelial-like” one (see Figure 7), similarly to what has
been observed in other cancer cells (Lv et al., 2012; Gulhati
et al., 2011). We found, in fact, a down-regulation of the EMT
player SNAIL upon prolonged starvation and Torin treatment
in our GBM models; this seems to be due to a general impair-
ment of the protein synthesis, as expected from the evidence
that the mTORC1 complex regulates mRNA translation
(Thoreen et al., 2012). Differently from starvation, that equally
affects both SNAIL and SLUG expression levels, Torin treat-
ment triggers SLUG down-regulation in GL15 but not in
U87MG cells, indicating that SLUG is differently regulated or
that it is more stable than SNAIL in U87MG cells. Our results
are in line with the previous evidence that SNAIL down-
regulation, by RNA interference, inhibitedmigration and inva-
sion of U87MG and other glioma cell lines (Han et al., 2011).
Notably, although both classified as IV grade GBMs, GL15
and U87MG show a very different phenotype and invasive
behavior, with mouse GL261 partially possessing some
U87MG-like features (Guillamo et al., 2001; Candolfi et al.,
2007; Szatmari et al., 2006). It is not surprising, therefore, to
observe differences between the two cell lines both in proteinFigure 7 e Proposed model illustrating the effect of autophagy on glioma
mesenchymal phenotype with absence of cellecell contacts, expression of S
cartoon). When autophagy is induced (right part of the cartoon), glioma ce
expression so acquiring an epithelial-like phenotype.pattern profiling and in response to stimuli; it is relevant that
the final migration outcome is similar upon autophagy
induction.
The decrease of SNAI proteins expression levels results in a
transcriptional and post-transcriptional increase in N- and R-
cadherin expression. Intriguingly, the increase of N- and R-
CAD mRNAs, upon Torin treatment, is less evident in U87MG
than in GL15 cells, where both SNAI levels are reduced, thus
supporting an important role for SLUG in CDH repression.
Whilst it is well known that loss of epithelial E-cadherin and
cell polarity promotes EMT in carcinomas, the contribution
of cadherins to the development of non-epithelial tumors is
less well documented (Onder et al., 2008; Gheldof and Berx,
2013). Classical cadherins are Ca2þ-dependent transmem-
brane proteins, which mediate homophilic interaction be-
tween adjacent cells and display a tissue-specific expression
(Wheelock and Johnson, 2003). Among others, E-cadherin
and N-cadherin are the most studied and are mainly
expressed in epithelial and in neural tissues, respectively. E-
cadherin expression in neural tissues is limited to stem cells
and specific areas and it is rare in GBM, although it has been
observed an abnormal E-cadherin expression in a subset of
highly aggressive GBM cells (Lewis-Tuffin et al., 2010). N-cad-
herin contributes to the polarity and migration of primary as-
trocytes (Camand et al., 2012). It has been observed that a
decreased N-cadherin expression is involved in the abnormal
migratory behavior of GBM cells, which -differently from as-
trocytes, are unable to polarize and show a faster and less-
directed migration; re-expression of N-cadherin in gliomas,
intriguingly, strongly reduces cell migration and restores po-
larity (Camand et al., 2012). The much less studied R-cadherin
is 74% identical to N-cadherin and can form heterodimers
with it in neural tissues. R-cadherin role in GBM tumorigen-
esis has not yet been investigated, but its inappropriate
expression in some epithelial cancer cells has been associated
with an increased cell motility, dependent on higher activa-
tion of the GTPases Rac1 and Cdc42 (Johnson et al., 2004).phenotype. When autophagy is off, glioma cells show a typical
NAI proteins that repress cadherin transcription (left part of the
lls loss SNAI proteins, with a consequent increase of cadherin
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degradation which may be responsible for the impairment of
cell movement as previously demonstrated in GBM cells
(Han et al., 2011). Despite promising preclinical studies, target-
ing mTOR in cancer therapy has shown limited clinical bene-
fits so far, probably due to the complexity of mTOR signaling;
mTORC1 inhibition, in fact, can stimulate proliferative and
pro-survival pathway (Dufour et al., 2011).
Further, Ambra1 and Beclin 1, both upstream regulators of
autophagy, have been recently shown to regulate cell cycle
progression besides their direct pro-autophagic activities
(Qu et al., 2003; Cianfanelli et al., 2014), this being a key factor
in tumorigenesis. However, approaches other than mTOR-
inhibiting drugs and autophagy blockers (such as chloroquine
or its derivatives), aimed at targeting and modulating the
autophagic process and its cross-talk with other cellular path-
ways are currently lacking in therapy. Therefore, we believe
that the findings presented here add important clues for
the definition of future therapeutic strategies targeting the
autophagic process as means to reduce the invasive proper-
ties of GBM, certainly one of the most serious obstacles to
complete tumor eradication with the current multimodal
therapy.4. Materials and methods
4.1. Cell cultures
Human GL-15 were kindly provided by Dr. E. Castigli, Perugia
University, Italy. Mouse GL261 cells were kindly provided by
Dr. S. Pellegatta, “C.Besta” Neurological Institute, Italy. All
cell lines were cultured in DMEM (Invitrogen) supplemented
with 10% heat-inactivated FBS (Invitrogen), 100 IU/ml peni-
cillin G, 100 mg/ml streptomycin, 2.5 mg/ml amphotericin B,
2 mM glutamine, and 1 mM sodium pyruvate. Cells were
grown at 37 C in a 5% CO2 humidified atmosphere.
Tumor specimens were obtained from the Department of
Neurosurgery, Neuromed, fromGBMpatientswho gave awrit-
ten informed consent to the research proposals. The study
was approved by the Institutional Ethics Committee of Neu-
romed and by Ministry of Health. Histopathological typing
and tumor grading were done according to the WHO criteria
resulting as grade IV (Sciaccaluga et al., 2013).
For autophagy induction, cells were treated with 250 nM
Torin 1 (SigmaeAldrich), 100 nM and 1 mM Rapamycin (Sigma-
eAldrich) or cultured in Earle’s Balanced Salt Solution
(SigmaeAldrich).
Where indicated, 3 mMMG132, 20 mMChloroquine (CQ) and
50 mg/ml Cycloheximide (CHX) were added to the media.
4.2. Lentiviral preparation and infection
15 mg retroviral vectorswas cotransfectedwith 5 mg expression
plasmid for the vesicular stomatitis virus G protein into
293 gp/bsr cell line by using the calcium phosphate method.
48 h later, the supernatant containing the retroviral particles
was recovered and supplemented with 4 mg/ml poly-brene.GL15 cells were infected by incubation with lentivirus-
containing supernatant for 6e8 h.
4.3. Wound healing assay
A wound-healing assay was used to compare the migratory
ability of GBM cells in control and autophagic conditions.
The same number of cells (4e9  104 cells/ml) were seeded
and cultured into the inner wells of cell culture inserts (Ibidi,
Germany) placed in a Petri dish. Once attached to the substra-
tum, the inserts were removed from the surface letting a
500 mm cell-free gap in which cells could migrate. To discrim-
inate the contributions of cell proliferation and migration to
wound closure, cell cycle blocker hydroxyurea (5 mM, Sigma-
eAldrich) was added for the time of the experiment. To
analyze the cell migration, the wounded areas were photo-
graphed at the indicated time points with CoolSNAP camera
(Photometrics) coupled to an ECLIPSE TieS phase contrast mi-
croscope (Nikon) and processed using ImageJ analysis soft-
ware (NIH). Percentage of wound healing was measured as
following: [1  (empty area X h/empty area 0 h)]  100.
4.4. Invasion assay
Sub-confluent cells were trypsinized, pre-incubated with or
without 250 nM Torin in invasion medium (DMEM without
glutamine supplemented with 100 IU/ml penicillin G and
100 mg/ml streptomycin or EBSS with 0.1% BSA and 25 mM
HEPES, pH 7.4) for 2 h, and plated at a density of
7  103 cells/cm2 on matrigel-coated transwells (8 mm pore
size, Costar). 100 nM CXCL12 (Peprotech) or vehicle were
added to the lower chamber of the transwell system. After
24 h (for U87MG, GL-15 and GBM primary cells) or 48 h (for
GL261) of incubation at 37 C, cells were treated with ice-
cold 10% trichloroacetic acid for 10 min. Cells adhering to
the upper side of the filter were scraped off, whereas cells
that have invaded through the insert were stained with a so-
lution containing 50% isopropanol, 1% formic acid and 0.5%
(wt/vol) brilliant blue R 250 (SigmaeAldrich) and counted in
more than 20 fields with a 20 objective. Data are the mean
of cells that have invaded through the insert  SE of at least
3 experiments.
4.5. Western blotting and antibodies
Proteins were separated on SDS-PAGE electrophoresis gel or
on NuPAGE Bis-Tris gel (Invitrogen) and electroblotted onto
nitrocellulose (Protran; Schleicher & Schuell). Blots were incu-
bated with primary antibodies in 5% nonfat dry milk in TBS
plus 0.1% Tween-20 overnight at 4 C. Detection was achieved
using horseradish peroxidase-conjugated secondary antibody
(Bio-Rad Laboratories) and visualized with ECL plus (GE
Healthcare). The following primary antibodies were used in
this study: anti-p70S6K and anti-phospho-p70S6K (Thr389),
anti-4EBP1 and anti-phospho-4EBP1 (Thr37/46), anti LC3,
anti- SNAIL, anti-SLUG (Cell Signaling), polyconal anti-p62,
anti-Beclin1 (Santa Cruz), anti-Actin and anti b-tubulin
(Sigma).
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After treatments, total RNA was extracted with the RNeasy
mini kit (Qiagen), following the producer’s instructions.
1e2 mg of total RNA was then retrotranscribed with oligodT
and M-MLV (Promega) and used for the quantitative PCR
(SYBR GREEN masetr mix, Roche) with the following primers:
for N-cadherin, 50-TATGCCCAAGACAAAGAGACC-30 (Fw) and
50-CAACTTCTGCTGACTCCTTCA-30 (Rev); for R-cadherin, 50-
CGAGTTCTGAGCTGTGCTATG-30 (Fw) and 50-GAGATTTC-
CAGTCCTTCCACTAC-30 (Rev); for P-cadherin, 50-ATGACTT-
CACTGTGCGGAAT-30 (Fw) and 50-CCAATCTCTCTTGTGTCTT
CGT-30 (Rev); for E-cadherin, 50-CTCCCTTCACAGCAGAAC-
TAAC-30 (Fw) and 50-CCACCTCTAAGGCCATCTTTG-30 (Rev).
Relative expression levels were calculated after normalization
over b-Actin.4.7. Statistical analysis
All experiments were performed at least three times. Sigma-
Plot software was used for statistical analysis. Statistical sig-
nificance was determined by using one-way analysis of
variance (ANOVA) followed by StudenteNewmaneKeuls or
StudenteHolmeSidak Method. *P < 0.05 was considered
significant.Conflict of interest
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